Cargando…
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441948/ http://dx.doi.org/10.1186/1742-4690-9-S2-P35 |
| _version_ | 1782243408391176192 |
|---|---|
| author | Alexander, J Gurwith, M Mendy, J Vang, L Manayani, D Avanzini, J Guenther, B Farness, P Haynes, BF Liao, H Montefiori, DC LaBranche, CC Mayall, T |
| author_facet | Alexander, J Gurwith, M Mendy, J Vang, L Manayani, D Avanzini, J Guenther, B Farness, P Haynes, BF Liao, H Montefiori, DC LaBranche, CC Mayall, T |
| author_sort | Alexander, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441948 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34419482012-09-18 Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein Alexander, J Gurwith, M Mendy, J Vang, L Manayani, D Avanzini, J Guenther, B Farness, P Haynes, BF Liao, H Montefiori, DC LaBranche, CC Mayall, T Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441948/ http://dx.doi.org/10.1186/1742-4690-9-S2-P35 Text en Copyright ©2012 Alexander et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Alexander, J Gurwith, M Mendy, J Vang, L Manayani, D Avanzini, J Guenther, B Farness, P Haynes, BF Liao, H Montefiori, DC LaBranche, CC Mayall, T Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title | Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title_full | Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title_fullStr | Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title_full_unstemmed | Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title_short | Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein |
| title_sort | development of a hiv-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing env clade c glycoprotein |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441948/ http://dx.doi.org/10.1186/1742-4690-9-S2-P35 |
| work_keys_str_mv | AT alexanderj developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT gurwithm developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT mendyj developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT vangl developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT manayanid developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT avanzinij developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT guentherb developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT farnessp developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT haynesbf developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT liaoh developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT montefioridc developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT labranchecc developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein AT mayallt developmentofahiv1vaccineusinganorallyadministeredreplicationcompetentadenovirusserotype4vectorexpressingenvcladecglycoprotein |